BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35631331)

  • 1. The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.
    Oekchuae S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Boonsombat J; Ruchirawat S; Tangkijvanich P; Suksamrarn A; Limpachayaporn P
    Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
    Limpachayaporn P; Nuchpun S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Tangkijvanich P; Suksamrarn A
    Bioorg Med Chem; 2022 Nov; 74():117048. PubMed ID: 36270111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines.
    Palakhachane S; Ketkaew Y; Chuaypen N; Sirirak J; Boonsombat J; Ruchirawat S; Tangkijvanich P; Suksamrarn A; Limpachayaporn P
    Bioorg Chem; 2021 Jul; 112():104831. PubMed ID: 33831675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
    Hou W; Fan Q; Su L; Xu H
    Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
    Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
    Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and antiproliferative evaluation of novel sorafenib analogs for the treatment of hepatocellular carcinoma.
    Jihad MI; Mahdi MF
    J Adv Pharm Technol Res; 2023; 14(3):274-279. PubMed ID: 37692003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using gene expression database to uncover biology functions of 1,4-disubstituted 1,2,3-triazole analogues synthesized via a copper (I)-catalyzed reaction.
    Su CL; Tseng CL; Ramesh C; Liu HS; Huang CF; Yao CF
    Eur J Med Chem; 2017 May; 132():90-107. PubMed ID: 28342400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents.
    Al-Blewi FF; Almehmadi MA; Aouad MR; Bardaweel SK; Sahu PK; Messali M; Rezki N; El Ashry ESH
    Chem Cent J; 2018 Nov; 12(1):110. PubMed ID: 30387018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.
    Varshosaz J; Raghami F; Rostami M; Jahanian A
    J Liposome Res; 2019 Dec; 29(4):383-398. PubMed ID: 30668221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib: a review of its use in advanced hepatocellular carcinoma.
    Keating GM; Santoro A
    Drugs; 2009; 69(2):223-40. PubMed ID: 19228077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation.
    Reda Aouad M; Almehmadi MA; Faleh Albelwi F; Teleb M; Tageldin GN; Abu-Serie MM; Hagar M; Rezki N
    Bioorg Chem; 2022 Jul; 124():105816. PubMed ID: 35489270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate.
    Sztanke M; Rzymowska J; Sztanke K
    Bioorg Med Chem; 2013 Dec; 21(23):7465-80. PubMed ID: 24126095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma.
    Shi Y; Wang X; Zhu Q; Chen G
    Front Oncol; 2021; 11():685694. PubMed ID: 34307151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.
    Gregorić T; Sedić M; Grbčić P; Tomljenović Paravić A; Kraljević Pavelić S; Cetina M; Vianello R; Raić-Malić S
    Eur J Med Chem; 2017 Jan; 125():1247-1267. PubMed ID: 27875779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.
    Xiao Y; Sun L; Fu Y; Huang Y; Zhou R; Hu X; Zhou P; Quan J; Li N; Fan XG
    BMC Cancer; 2017 Dec; 17(1):857. PubMed ID: 29246127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
    Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
    Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,3-Triazole-Functionalized Polysulfone Synthesis through Microwave-Assisted Copper-Catalyzed Click Chemistry: A Highly Proton Conducting High Temperature Membrane.
    Sood R; Donnadio A; Giancola S; Kreisz A; Jones DJ; Cavaliere S
    ACS Appl Mater Interfaces; 2016 Jul; 8(26):16897-906. PubMed ID: 27243583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.